SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-17-011006
Filing Date
2017-10-27
Accepted
2017-10-27 13:31:18
Documents
44
Period of Report
2017-05-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0517_nexusbiopharma.htm 10-Q 267243
2 CERTIFICATION f10q0517ex31-1_nexusbiohtm.htm EX-31.1 13914
3 CERTIFICATION f10q0517ex32-1_nexusbiohtm.htm EX-32.1 5327
  Complete submission text file 0001213900-17-011006.txt   1875448

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE nexs-20170531.xml EX-101.INS 289520
5 XBRL SCHEMA FILE nexs-20170531.xsd EX-101.SCH 28017
6 XBRL CALCULATION FILE nexs-20170531_cal.xml EX-101.CAL 21326
7 XBRL DEFINITION FILE nexs-20170531_def.xml EX-101.DEF 70737
8 XBRL LABEL FILE nexs-20170531_lab.xml EX-101.LAB 217351
9 XBRL PRESENTATION FILE nexs-20170531_pre.xml EX-101.PRE 144966
Mailing Address JLABS @ TMCX 2450 HOLCOMBE BOULEVARD, SUITE J HOUSTON TX 77021-2040
Business Address JLABS @ TMCX 2450 HOLCOMBE BOULEVARD, SUITE J HOUSTON TX 77021-2040 (346) 772-0351
NEXUS BIOPHARMA INC (Filer) CIK: 0001424151 (see all company filings)

IRS No.: 753267338 | Fiscal Year End: 0228
Type: 10-Q | Act: 34 | File No.: 000-53207 | Film No.: 171158822
SIC: 2834 Pharmaceutical Preparations